Making sure cancer drugs hit their target

Simply knowing that a new candidate drug for leukemia worked in laboratory tests wasn’t enough for Chris Vakoc and his team. They set out to pinpoint how the drug works by developing an efficient, rigorous, and broadly applicable technique for assessing the mechanism of new drugs, not only ones targeting cancer. Read more.